Amazon One Medical offer

Amazon is pushing deeper into weight-loss care with a new One Medical program that combines doctor visits, prescriptions and pharmacy delivery in one service. (health.amazon.com) The program is available nationwide through Amazon One Medical, and Amazon said it folds obesity treatment into routine primary care instead of treating it as a one-time prescription. It includes virtual and in-person visits, pre-visit screening, regular follow-ups and prescription management. (cnbc.com) (fiercehealthcare.com) Amazon’s site says patients start by answering questions about their health goals, then meet a licensed provider who decides whether a glucagon-like peptide-1 drug is appropriate. Those drugs mimic a gut hormone that helps people feel full longer and eat less. (health.amazon.com) Amazon said insured patients could pay as little as $25 a month for some GLP-1 medicines through Amazon Pharmacy. For cash-pay patients, oral drugs start at $149 a month and injectable treatments including Wegovy and Zepbound start at $299 a month. (cnbc.com) The company is also using its delivery network as part of the pitch. Amazon said GLP-1 medications can be delivered in all 50 states, with same-day delivery in nearly 3,000 cities and an expansion to nearly 4,500 cities planned by the end of 2026. (fiercehealthcare.com) Amazon’s page lists semaglutide and tirzepatide options, including Wegovy and Zepbound, plus oral medicines such as Wegovy pill and Eli Lilly’s Foundayo. The site says the medication itself is billed separately from the treatment program. (health.amazon.com) The company is entering a market where patients have often bounced between telehealth prescribers, insurers and pharmacies to start treatment or keep refills coming. Fierce Healthcare reported Amazon framed the service as a way to reduce fragmented care and unclear costs. (fiercehealthcare.com) Other retailers are making similar moves. Walmart said on April 16 that it expanded its Better Care Services platform to connect customers with virtual weight-management care, nutrition support and prescription access for GLP-1 drugs through its pharmacy network. (corporate.walmart.com) The backdrop has also shifted on supply and regulation. The Food and Drug Administration said in February 2025 that the shortage of semaglutide injection products was resolved, a change that tightened the path for many compounders that had moved in during shortages. (fda.gov) Amazon’s bet is that weight-loss treatment will look more like ordinary primary care: screening first, ongoing check-ins after that, and the prescription arriving like any other refill. (health.amazon.com)